Source: Annual Congress 2003 - Mesothelioma and malignant effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kovkarova, T. Stefanovski, D. Dokic, B. Kaeva, O. Jovkovski (Skopje, Macedonia). Telomerase activity as additional diagnostic tool in pleural malignant effusions. Eur Respir J 2003; 22: Suppl. 45, 490

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic implications of telomerase activity in pleural effusions Source: Eur Respir J 2003; 22: 422-426 Year: 2003 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Diagnostic implications of telomerase activity in pleural effusions Source: Eur Respir J 2004; 23: 653-654 Year: 2004 Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 An algorithm for the investigation of isolated suspected malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003 Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions Source: Annual Congress 2009 - Pleural diseases Year: 2009 Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006 Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Value of chitotriosidase enzyme activity in discrimination of tuberculous pleurisy from malignant pleural effusion Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010 Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Closed percutaneous pleural brushing: a novel diagnostic approach for diagnosis of malignant pleural effusions Source: Eur Respir J 2007; 30: Suppl. 51, 102s Year: 2007 In search of an ideal method to diagnose tuberculous pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 612s Year: 2006 Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=173 Year: 2005 Sonographic echogenic swirling pattern in patients with malignancies: a useful diagnostic predictor for malignant pleural effusions Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases Year: 2008 The value of thoracoscopy in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001